bromocriptine has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boo, DH; Choi, HJ; Hwang, O; Kang, BY; Kim, EM; Kim, SS; Lim, JH; No, H | 1 |
| Bai, S; Gao, J; Han, L; Li, H; Tian, Y; Wang, R; Wei, C; Wu, L; Xu, C; Yang, G; Zhao, Y | 1 |
2 other study(ies) available for bromocriptine and cytochrome c-t
| Article | Year |
|---|---|
Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Topics: Animals; Antioxidants; Biopterins; Bromocriptine; Cell Death; Cell Line; Cytochromes c; Dopamine; Dopamine Agonists; Enzymes; L-Lactate Dehydrogenase; Mice; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Receptors, Dopamine; Signal Transduction; Up-Regulation | 2009 |
Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis.
Topics: Animals; Apoptosis; Bromocriptine; Calcium; Cardiotonic Agents; Caspase 3; Caspase 9; Cell Hypoxia; Cell Survival; Cytochromes c; Dopamine Agonists; Dopamine Antagonists; Extracellular Signal-Regulated MAP Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Ischemic Postconditioning; KATP Channels; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C-epsilon; Protein Transport; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Receptors, Dopamine D2; RNA, Messenger; Signal Transduction | 2014 |